Cost-Effective Sterilization Method

Regulatory agencies, including the FDA and EMA, prefer terminal sterilization over aseptic manufacturing, as it is less complex, less costly, and easily reproducible―providing a higher level of sterility assurance and patient safety. Sterilization also takes place after formulation, once the product has been filled into the primary packaging, making it the optimal choice.

Learn more about our expertise and find out if terminal sterilization is suitable for your product.

Questions? Speak with one of our experts.

Related resources that may interest you:

Webinar: Advantages of Terminal Sterilization Over Aseptic Manufacturing                                                    
Scientific Journal: Terminal Sterilization of Pharmaceutical products

                             
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.